Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03188653 · ClinicalTrials.gov registry record · NA

Evaluating the Effects of Cleansers on the Skin

A NA study, sponsored by University of Arizona.

Terminated
Registry status
NA
Development phase
20
Enrollment target

NCT03188653 is a NA study that was terminated before completion, run by University of Arizona. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03188653, a NA study, was terminated before completion, sponsored by University of Arizona.

TERMINATED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One spot will serve as a control and not receive any cleanser. Each spot will be cleansed with the corresponding cleanser for 15 seconds then rinsed off with tap water. Skin barrier will be measured at baseline, immediately after, 30, 60 and 90 minutes after rinse off.

Interventions

  • OTHER CeraVe® Eczema Soothing Body Wash
  • OTHER Cetaphil® RestoraDerm® Eczema Calming Body Wash
  • OTHER Dove® Sensitive Skin Body Wash
  • OTHER Eucerin® Skin Calming Body Wash
  • OTHER Aveeno® Skin Relief Body Wash

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-05-31
Est. Completion 2020-05-31
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT03188653

The ClinicalTrials.gov registry entry for NCT03188653 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 5 interventions - of which CeraVe® Eczema Soothing Body Wash is the first listed.

NCT03188653 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03188653 about?

NCT03188653 is a clinical study titled "Evaluating the Effects of Cleansers on the Skin". This will be a single visit study that will take approximately 2 hours. Up to 50 subjects (up to 25 healthy subjects, and up to 25 subjects with AD) from BUMC dermatology clinics will be enrolled in this study and randomized to receive the 7 cleansers on 7 test spots on their upper extremities. One ...

What is the current status of trial NCT03188653?

This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-31. Estimated completion is 2020-05-31.

What interventions are being tested in trial NCT03188653?

The interventions under investigation include: CeraVe® Eczema Soothing Body Wash (OTHER), Cetaphil® RestoraDerm® Eczema Calming Body Wash (OTHER), Dove® Sensitive Skin Body Wash (OTHER), Eucerin® Skin Calming Body Wash (OTHER), Aveeno® Skin Relief Body Wash (OTHER).

Who is sponsoring clinical trial NCT03188653?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.